US FDA Approves Novartis Pharmaceuticals Corporation (NVS) (JOBS) Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
8/17/2009 6:40:58 AM
More...
|
FDA Approves Novartis Pharmaceuticals Corporation (NVS)'s (JOBS) Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
7/21/2009 8:01:53 AM
More...
|
FDA Approves Novartis Pharmaceuticals Corporation (NVS)'s (JOBS) Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
5/1/2009 7:38:52 AM
More...
|
Novartis Pharmaceuticals Corporation (NVS)'s Gleevec(R) Substantially Reduces Risk of Cancer Returning in Patients with Life-Threatening Gastrointestinal Stromal Tumors, Lancet Reports
3/19/2009 10:44:12 AM
More...
|
Novartis Pharmaceuticals Corporation (NVS) Release: Patients With Early Parkinson’s Disease Experienced Better Symptom Control And Improvements In Daily Activities With Stalevo(R) Than Carbidopa/Levodopa, According To Newly-Published Study
12/17/2008 12:39:17 PM
More...
|
MDRNA, Inc. Announces Tentative FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis
12/15/2008 10:18:54 AM
More...
|
Novartis Pharmaceuticals Corporation (NVS)'s Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
12/11/2008 9:28:23 AM
More...
|
FDA Approves 30-Minute Onset of Action for Novartis Pharmaceuticals Corporation (NVS)'s Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
11/12/2008 8:21:01 AM
More...
|
Novartis Pharmaceuticals Corporation (NVS) Release: Two New Dosage Strengths Of Stalevo(R) Approved In The U.S. Provide Greater Dosing Flexibility For People With Parkinson’s Disease
10/29/2008 8:48:37 AM
More...
|
Novartis Pharmaceuticals Corporation (NVS) Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
10/8/2008 11:07:56 AM
More...
|
|